Pafolacianine

Last Updated: 06/30/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

An Octopus probe for high-performance >1,300 nm NIR-II fluorescence molecular imaging of cancer.

An Octopus probe for high-performance >1,300 nm NIR-II fluorescence molecular imaging of cancer.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: April 28, 2026

αvβ3 integrin-targeted IR-820 dye-based small molecule probe for fluorescence imaging of tumor.

αvβ3 integrin-targeted IR-820 dye-based small molecule probe for fluorescence imaging of tumor.

Journal: Journal of photochemistry and photobiology. B, Biology

Published: February 26, 2026

Design of a Pan-Tumor Fluorescence Imaging Cocktail for Fluorescence-Guided Surgery.

Design of a Pan-Tumor Fluorescence Imaging Cocktail for Fluorescence-Guided Surgery.

Journal: Bioconjugate chemistry

Published: December 18, 2025

Widespread folate receptor expression in pediatric and adolescent solid tumors - opportunity for intraoperative visualization with the novel fluorescent agent pafolacianine.

Widespread folate receptor expression in pediatric and adolescent solid tumors - opportunity for intraoperative visualization with the novel fluorescent agent pafolacianine.

Journal: Oncotarget

Published: October 16, 2025

Considerations for the use of targeted fluorescence contrast agents to detect circulating cancer cell populations with diffuse in vivo flow cytometry.

Considerations for the use of targeted fluorescence contrast agents to detect circulating cancer cell populations with diffuse in vivo flow cytometry.

Journal: Journal of biomedical optics

Published: September 02, 2025

Clinical fluorescent contrast agents for image-guided surgery.

Clinical fluorescent contrast agents for image-guided surgery.

Journal: Fundamental research

Published: August 22, 2025

Evaluation of Pafolacianine (Cytalux®) for Fluorescence-Guided Surgery in Head and Neck Squamous Cell Carcinoma: A Negative Study with Important Clinical Implications.

Evaluation of Pafolacianine (Cytalux®) for Fluorescence-Guided Surgery in Head and Neck Squamous Cell Carcinoma: A Negative Study with Important Clinical Implications.

Journal: Molecular imaging and biology

Published: August 08, 2025

Considerations for the use of contrast agents with diffuse in vivo flow cytometry to detect circulating cancer cell populations.

Considerations for the use of contrast agents with diffuse in vivo flow cytometry to detect circulating cancer cell populations.

Journal: bioRxiv : the preprint server for biology

Published: August 06, 2025

Is seeing believing?-signal differentiation in a preclinical transbronchial imaging study implementing a composite optical fiber bronchoscope to detect a folate receptor-targeted near-infrared fluorophore.

Is seeing believing?-signal differentiation in a preclinical transbronchial imaging study implementing a composite optical fiber bronchoscope to detect a folate receptor-targeted near-infrared fluorophore.

Journal: Translational lung cancer research

Published: May 28, 2025

Intraoperative pafolacianin for nodule detection during VATS metastasectomy in extremity metastatic sarcoma surgery performed concurrently.

Intraoperative pafolacianin for nodule detection during VATS metastasectomy in extremity metastatic sarcoma surgery performed concurrently.

Journal: Journal of cardiothoracic surgery

Published: May 18, 2025

Application of fluorescent tracers in ovarian cancer surgical navigation: a systematic review and meta-analysis.

Application of fluorescent tracers in ovarian cancer surgical navigation: a systematic review and meta-analysis.

Journal: World journal of surgical oncology

Published: May 12, 2025

Enhancing surgical precision in ovarian cancer with FRα-fluorescence-guided surgery.

Enhancing surgical precision in ovarian cancer with FRα-fluorescence-guided surgery.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: March 04, 2025

Showing 1-12 of 38

Last Updated: 06/30/2026